{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:51:22Z","timestamp":1780390282472,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00296-018-4189-8","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T06:24:48Z","timestamp":1540880688000},"page":"377-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cyclophosphamide-induced severe acute hepatitis in a rheumatic disease: case-based review"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-3905","authenticated-orcid":false,"given":"D\u00f6nd\u00fc","family":"\u00dcsk\u00fcdar Cansu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-7492","authenticated-orcid":false,"given":"Erkin","family":"\u00d6zta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-0699","authenticated-orcid":false,"given":"Cengiz","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"4189_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/FTD.0b013e31826a6306","volume":"34","author":"MG Anelli","year":"2012","unstructured":"Anelli MG, Scioscia C, Grattagliano I, Lapadula G (2012) Old and new antirheumatic drugs and the risk of hepatotoxicity. Ther Drug Monit 34:622\u2013628","journal-title":"Ther Drug Monit"},{"key":"4189_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.rdc.2017.09.003","volume":"44","author":"PR Wood","year":"2018","unstructured":"Wood PR, Caplan L (2018) Drug-induced gastrointestinal and hepatic disease associated with biologics and nonbiologic disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 44:29\u201343","journal-title":"Rheum Dis Clin North Am"},{"key":"4189_CR3","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1517\/14656566.2015.1101448","volume":"16","author":"MW Tsang-A-Sjoe","year":"2015","unstructured":"Tsang-A-Sjoe MW, Bultink IE (2015) Systemic lupus erythematosus: review of synthetic drugs. Expert Opin Pharmacother 16:2793\u20132806","journal-title":"Expert Opin Pharmacother"},{"key":"4189_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7326\/0003-4819-97-1-62","volume":"97","author":"AM Bacon","year":"1982","unstructured":"Bacon AM, Rosenberg SA (1982) Cyclophosphamide hepatotoxicity in a patient with systemic lupus erythematosus. Ann Intern Med 97:62\u201363","journal-title":"Ann Intern Med"},{"key":"4189_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.12659\/AJCR.889401","volume":"14","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Cader RA, Mohd R, Yen KW, Ghafor HA (2013) Low-dose cyclophosphamide-induced acute hepatotoxicity. Am J Case Rep 14:345\u2013349","journal-title":"Am J Case Rep"},{"key":"4189_CR6","first-page":"496","volume":"31","author":"M Mart\u00ednez-Gabarr\u00f3n","year":"2011","unstructured":"Mart\u00ednez-Gabarr\u00f3n M, Enr\u00edquez R, Sirvent AE, Garc\u00eda-Sepulcre M, Mill\u00e1n I, Amor\u00f3s F (2011) Hepatotoxicity following cyclophosphamide treatment in a patient with MPO-ANCA vasculitis. Nefrologia 31:496\u2013498","journal-title":"Nefrologia"},{"key":"4189_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1572-0241.2000.01875.x","volume":"95","author":"CC Mok","year":"2000","unstructured":"Mok CC, Wong WM, Shek TW, Ho CT, Lau CS, Lai CL (2000) Cumulative hepatotoxicity induced by continuous low-dose cyclophosphamide therapy. Am J Gastroenterol 95:845\u2013846","journal-title":"Am J Gastroenterol"},{"key":"4189_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1445-5994.1993.tb01447.x","volume":"23","author":"BD Cleland","year":"1993","unstructured":"Cleland BD, Pokorny CS (1993) Cyclophosphamide related hepatotoxicity. Aust N Z J Med 23:408","journal-title":"Aust N Z J Med"},{"key":"4189_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1365-2796.1996.42867000.x","volume":"240","author":"LL Gustafsson","year":"1996","unstructured":"Gustafsson LL, Eriksson LS, Dahl ML, Eleborg L, Ericzon BG, Nyberg A (1996) Cyclophosphamide-induced acute liver failure requiring transplantation in a patient with genetically deficient debrisoquine metabolism: a causal relationship? J Intern Med 240:311\u2013314","journal-title":"J Intern Med"},{"key":"4189_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0025-6196(12)60074-3","volume":"68","author":"LS Snyder","year":"1993","unstructured":"Snyder LS, Heigh RI, Anderson ML (1993) Cyclophosphamide-induced hepatotoxicity in a patient with Wegener\u2019s granulomatosis. Mayo Clin Proc 68:1203\u20131204","journal-title":"Mayo Clin Proc"},{"key":"4189_CR11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/01.smj.0000251467.62842.ad","volume":"99","author":"H Akay","year":"2006","unstructured":"Akay H, Akay T, Secilmis S, Kocak Z, Donderici O (2006) Hepatotoxicity after low-dose cyclophosphamide therapy. South Med J 99:1399\u20131400","journal-title":"South Med J"},{"key":"4189_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","volume":"7","author":"GP Aithal","year":"2011","unstructured":"Aithal GP (2011) Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol 7:139\u2013150","journal-title":"Nat Rev Rheumatol"},{"key":"4189_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245","journal-title":"Clin Pharmacol Ther"},{"key":"4189_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2217\/pgs.09.134","volume":"10","author":"N Pinto","year":"2009","unstructured":"Pinto N, Ludeman SM, Dolan ME (2009) Drug focus: pharmacogenetic studies related to cyclophosphamide-based therapy. Pharmacogenomics 10:1897\u20131903","journal-title":"Pharmacogenomics"},{"key":"4189_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/sj.bjc.6603097","volume":"94","author":"ME Jonge","year":"2006","unstructured":"Jonge ME, Huitema AD, Beijnen JH, Rodenhuis S (2006) High exposures to bioactivated cyclophosphamide are related to the occurrence of venoocclusive disease of the liver following high-dose chemotherapy. Br J Cancer 94:1226\u20131230","journal-title":"Br J Cancer"},{"key":"4189_CR16","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF, Schoch HG, Anasetti C, Gooley T (2003) Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 101:2043\u20132048","journal-title":"Blood"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4189-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4189-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4189-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T17:03:27Z","timestamp":1572455007000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4189-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4189-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author DUC, Author E\u00d6, Author EY and Author CK declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from our patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}